<abstract xmlns="http://www.w3.org/1999/xhtml">

<p>The combination of osteoporosis and sarcopenia is wider known as “osteosarcopenia”, and it is considered to be a “hazardous duet” for the patient. The clinical consequences of this geriatric syndrome include a higher risk of fractures and mortality compared to osteoporosis or sarcopenia alone. Fractures are considered to be a burden for the patient but also for the health care system from an economic point of view, therefore it is important to prevent them. Emerging evidence shows that osteosarcopenia is an increasingly prevalent disease. The Fracture Risk Assessment Tool (FRAX) is of major importance for the management of a patient, however, muscle weakness is not part of this instrument. It has been suggested to go “beyond the FRAX” and to evaluate muscle mass/strength besides bone mineral density when it comes to the management of a patient with a sustained fragility fracture. In this review we try to answer whether this is feasible or not when it comes to Romanian patients.</p>
</abstract>

The combination of osteoporosis and sarcopenia is wider known as “osteosarcopenia”, and it is considered to be a “hazardous duet” for the patient. The clinical consequences of this geriatric syndrome include a higher risk of fractures and mortality compared to osteoporosis or sarcopenia alone. Fractures are considered to be a burden for the patient but also for the health care system from an economic point of view, therefore it is important to prevent them. Emerging evidence shows that osteosarcopenia is an increasingly prevalent disease. The Fracture Risk Assessment Tool (FRAX) is of major importance for the management of a patient, however, muscle weakness is not part of this instrument. It has been suggested to go “beyond the FRAX” and to evaluate muscle mass/strength besides bone mineral density when it comes to the management of a patient with a sustained fragility fracture. In this review we try to answer whether this is feasible or not when it comes to Romanian patients.

Should we screen for sarcopenia in Romanian patients with osteoporosis? An overview of the current knowledge on osteosarcopenia

University of Medicine,Pharmacy, Science, and Technology of Targu Mures

Acta Marisiensis - Seria Medica

This work is licensed under the Creative Commons Attribution 4.0 International License.

The combination of osteoporosis and sarcopenia is wider known as “osteosarcopenia”, and it is considered to be a “hazardous duet” for the patient. The clinical...

Should we screen for sarcopenia in Romanian patients with osteoporosis? An overview of the current knowledge on osteosarcopenia

Published Online: Jun 30, 2023

Page range: 93 - 97

Received: Jan 23, 2023

Accepted: Mar 13, 2023

DOI: https://doi.org/10.2478/amma-2023-0014

Keywords
osteoporosis, sarcopenia, osteosarcopenia

© 2023 Gabriela Mihai et al., published by Sciendo

This work is licensed under the Creative Commons Attribution 4.0 International License.

Should we screen for sarcopenia in Romanian patients with osteoporosis? An overview of the current knowledge on osteosarcopenia

Published Online: Jun 30, 2023

Page range: 93 - 97

Received: Jan 23, 2023

Accepted: Mar 13, 2023

DOI: https://doi.org/10.2478/amma-2023-0014

Keywordsosteoporosis, sarcopenia, osteosarcopenia

© 2023 Gabriela Mihai et al., published by Sciendo

This work is licensed under the Creative Commons Attribution 4.0 International License.

Keywords
osteoporosis, sarcopenia, osteosarcopenia